JP Stock MarketDetailed Quotes

4588 Oncolys BioPharma

Watchlist
  • 579
  • -29-4.77%
20min DelayTrading Jan 23 09:15 JST
14.45BMarket Cap-5.32P/E (Static)

Oncolys BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oncolys BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 12, 20232023/Q135.000M / ----
Nov 4, 20222022/Q3358.000M / ----
May 13, 20222022/Q1193.000M / ----
Nov 5, 20212021/Q3125.000M / ----
May 7, 20212021/Q162.000M / ----
DatePeriodRevenue/EstimateEarnings Call
May 12, 20232023/Q135.000M / ----
Nov 4, 20222022/Q3358.000M / ----
May 13, 20222022/Q1193.000M / ----
Nov 5, 20212021/Q3125.000M / ----
May 7, 20212021/Q162.000M / ----

Unlock Free Earnings Estimates

Oncolys BioPharma Earnings Reports

  • Oncolys BioPharma: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

    Nov 7, 2024 23:00 ET

  • Oncolys BioPharma: Confirmation letter

    Aug 9, 2024 02:07 ET

  • Oncolys BioPharma: Half Year Report - Term 21 (2024/01/01 - 2024/12/31)

    Aug 9, 2024 02:07 ET

  • Oncolys BioPharma: Financial results for the second quarter (interim period) of the December 2024 fiscal year based on Japanese standards (non-consolidated).

    Aug 9, 2024 02:00 ET

    • Read more

    Top JP Stock Gainers
    Symbol Price % Chg
    Ensuiko Sugar Refining
    2112
    377 +19.30%
    Reyuu Japan
    9425
    475 +16.14%
    Land
    8918
    8 +14.29%
    The Why How Do
    3823
    53 +12.77%
    Twenty-four seven
    7074
    388 +11.82%

    See the daily top gainer.